Mobile Button Search>
Pre-IND
Phase I
Phase II
Phase III
Registration
Marketed

Hematology

P1101
PV (EU)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Hematology

P1101
PV (TW)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Hematology

P1101
PV (US)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Hematology

P1101
PV (KR)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Hematology

P1101
PV (JP, CN)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Hematology

P1101
ET (Global)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Hematology

Next Generations of P1101
MPN (Global)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Oncology

P1101 + anti PD-1
HCC (Global)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Oncology

Oraxol
Breast Cancer (TW, SG, VN)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Oncology

Oraxol + Ramucirumab
Gastric Cancer (TW, SG, VN)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Oncology

P1101
Solid Tumors (Global)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Infectious Disease

P1101
HDV (US, EU, TW)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Dermatology

KX01
Psoriasis (TW, CN, HK, MO, MY, SG)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Dermatology

KX01
Actinic Keratosis (TW)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA